Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 30, 2009, Pages 3857-3864

  Murray, Gordon J ^a,b   Danaceau, Jonathan P ^b  

^a UNIVERSITY OF UTAH   (United States)

^b Sports Medicine Research and Testing Laboratory   (United States)

Author keywords

Beta blockers; Diuretics; Doping; Stimulants; Tandem mass spectrometry; UPLC; Urine

Indexed keywords

BETA-BLOCKERS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HPLC-MS/MS; HUMAN URINE; INTERNATIONAL STANDARDS; ISO 17025; POLARITY SWITCHING; QUALITATIVE METHOD; REVERSED PHASE HPLC; ROUTINE ANALYSIS; SIMULTANEOUS DETERMINATIONS; SOLID PHASE EXTRACTION METHOD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPLC-MS/MS; URINE ANALYSIS; URINE SAMPLE;

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY;

EXTRACTION;

ACEBUTOLOL; ACETAZOLAMIDE; ALPRENOLOL; AMFEBUTAMONE; AMILORIDE; ATENOLOL; BENDROFLUMETHIAZIDE; BENZOYLECGONINE; BENZTHIAZIDE; BETAXOLOL; BISOPROLOL; BUMETANIDE; CANRENOIC ACID; CARPHEDON; CHLOROTHIAZIDE; CHLORTALIDONE; CLOPAMIDE; CYCLOTHIAZIDE; DICLOFENAMIDE; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; INDAPAMIDE; METOLAZONE; MODAFINIL; PROBENECID; TRIAMTERENE; TRICHLORMETHIAZIDE; UNINDEXED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RELIABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; VALIDATION PROCESS;

ADRENERGIC BETA-ANTAGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIURETICS; HUMANS; NEUROTRANSMITTER AGENTS; STEROIDS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 72049113106     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.09.036     Document Type: Article

References (26)

1. Delbeke F.T., and Debackere M. Biopharm. Drug Disp. 9 (1988) 137
2. Van Eenoo P., and Delbeke F.T. Int. J. Sports Med. 24 (2003) 565
3. WADA, The World Anti-Doping Code, The 2008 Prohibited List, International Standard, 2008. http://www.wada-ama.org.
4. Barroso M.B., Meiring H.D., de Jong A., Alonso R.M., and Jiménez R.M. J. Chromatogr. B: Biomed. Sci. Appl. 690 (1997) 105
5. Beyer J., Bierl A., Peters F.T., and Maurer H.H. Ther. Drug Monitor. 27 (2005) 509
6. Morra V., Davit P., Capra P., Vincenti M., Di Stilo A., and Botrè F. J. Chromatogr. A 1135 (2006) 219
7. Brunelli C., Bicchi C., Di Stilo A., Salomone A., and Vincenti M. J. Sep. Sci. 29 (2006) 2765
8. Guddant S., Thevis M., and Schänzer W. Eur. J. Mass Spectrom. 14 (2008) 127
9. Carreras D., Imaz C., Navajas R., Garcia M.A., Rodriguez C., Rodriguez A.F., and Cortes R. J. Chromatogr. A 683 (1994) 195
10. Devnter K., Van Eenoo P., and Delbeke F.T. Rapid Commun. Mass Spectrom. 19 (2005) 90
11. Mazzarino M., de la Torre X., and Botrè F. Anal. Bioanal. Chem. 392 (2008) 681
12. Mazzarino M., Fiacco I., de la Torre X., and Botrè F. Eur. J. Mass Spectrom. 14 (2008) 171
13. Thöngren J.-O., Östervall F., and Garle M. J. Mass Spectrom. 43 (2008) 980
14. Ventura R., Roig M., Montfort N., Sáez P., Bergés R., and Segura J. Eur. J. Mass Spectrom. 14 (2008) 191
15. Black S.B., Stenhouse A.M., and Hanson R.C. J. Chromatogr. B 685 (1996) 67
16. Hemmersbach P., and de la Torre R. J. Chromatogr. B 687 (1996) 221
17. Paik M.J., Lee J., and Kim K.R. Anal. Chim. Acta 601 (2007) 230 (and references contained therein)
18. Thevis M., and Schänzer W. Mass Spectrom. Rev. 26 (2007) 79
19. Georgakopoulos C.G., Vonaparti A., Stamou M., Kiousi P., Lyris E., Angelis Y.S., Tsoupras G., Wuest B., Nielen M.W., Panderi I., and Koupparis M. Rapid Commun. Mass Spectrom. 21 (2007) 2439
20. Kolmonen M., Leinonen A., Pelander A., and Ojanpera I. Anal. Chim. Acta 585 (2007) 94
21. Phenomenex Luna Phenyl Hexyl (100 mm L × 2.1 mm ID, 3.5 μm particle size) and Varian Polaris C18 (150 mm L × 2.0 mm ID, 3.5 μm particle size) analytical columns were also evaluated.
22. A Waters Acquity™ BEH C18 (50 mm L × 2.1 mm ID, 1.7 μm particle size) analytical column was also evaluated.
23. WADA, The World Anti-Doping Agency, Technical Document-TD2009MRPL, version 1.0. http://www.wada-ama.org.
24. International Organization for Standardization, General requirements for the competence of testing and calibration laboratories, ISO:17025. http://www.iso.org.
25. Miller J.N., and Miller J.C. Statistics and Chemometrics for Analytical Chemistry. fourth ed. (2000), Prentice Hall, England
26. Goebel C., Trout G.J., and Kazlauskas R. Anal. Chim. Acta 502 (2004) 65